Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer-Reference-Cited by-同舟云学术

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Published:2023-05-04 Issue:18 Volume:388 Page:1645-1656
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Partridge Ann H.¹,Niman Samuel M.¹,Ruggeri Monica¹,Peccatori Fedro A.¹^ORCID,Azim Hatem A.¹,Colleoni Marco¹,Saura Cristina¹,Shimizu Chikako¹,Sætersdal Anna B.¹,Kroep Judith R.¹,Mailliez Audrey¹,Warner Ellen¹,Borges Virginia F.¹,Amant Frédéric¹,Gombos Andrea¹,Kataoka Akemi¹^ORCID,Rousset-Jablonski Christine¹,Borstnar Simona¹,Takei Junko¹,Lee Jeong E.¹,Walshe Janice M.¹,Ruíz-Borrego Manuel¹,Moore Halle C.F.¹,Saunders Christobel¹,Bjelic-Radisic Vesna¹,Susnjar Snezana¹,Cardoso Fatima¹,Smith Karen L.¹,Ferreiro Teresa¹,Ribi Karin¹^ORCID,Ruddy Kathryn¹,Kammler Roswitha¹,El-Abed Sarra¹,Viale Giuseppe¹,Piccart Martine¹,Korde Larissa A.¹,Goldhirsch Aron¹,Gelber Richard D.¹,Pagani Olivia¹

Affiliation:

1. From the Department of Medical Oncology, Dana–Farber Cancer Institute (A.H.P.), Harvard Medical School (A.H.P., R.D.G.), the International Breast Cancer Study Group Statistical Center and the Department of Data Science, Division of Biostatistics, Dana–Farber Cancer Institute (S.M.N., R.D.G.), and Frontier Science and Technology Research Foundation and Harvard T.H. Chan School of Public Health (R.D.G.) — all in Boston; the International Breast Cancer Study Group (M.R., K. Ribi, R.K., G.V., A. Goldhirsch)...

Funder

ETOP IBCSG Partners Foundation

Alliance for Clinical Trials in Oncology

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2212856

Reference26 articles.

1. Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged ≥20 Years — United States, 1999–2018

2. International variation in breast cancer incidence and mortality in young women